Amgen Inc.AMGNNASDAQ
Loading
EBITDA Margin Over TimeStable
Percentile Rank29
3Y CAGR-2.3%
5Y CAGR-3.3%
Year-over-Year Change
EBITDA as a percentage of revenue
3Y CAGR
-2.3%/yr
vs -3.9%/yr prior
5Y CAGR
-3.3%/yr
Consistent
Acceleration
+1.6pp
Accelerating
Percentile
P29
Within normal range
vs 5Y Ago
0.8x
Contraction
Streak
1 yr
Consecutive growthStable
| Period | Value | YoY Change |
|---|---|---|
| 2025 | 43.12% | +7.9% |
| 2024 | 39.96% | -23.9% |
| 2023 | 52.50% | +13.6% |
| 2022 | 46.23% | +6.3% |
| 2021 | 43.48% | -14.9% |
| 2020 | 51.12% | -5.5% |
| 2019 | 54.07% | -0.3% |
| 2018 | 54.25% | -3.6% |
| 2017 | 56.27% | +3.3% |
| 2016 | 54.49% | - |